Clinical Trial Detail

NCT ID NCT02470091
Title Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements no
Sponsors Children's Oncology Group
Indications

osteosarcoma

Therapies

Denosumab

Age Groups: child adult

No variant requirements are available.